Wim Jiskoot
Wim Jiskoot
Leiden University, Coriolis Pharma
Verified email at lacdr.leidenuniv.nl
Title
Cited by
Cited by
Year
Critical evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates
V Filipe, A Hawe, W Jiskoot
Pharmaceutical research 27 (5), 796-810, 2010
13952010
Extrinsic fluorescent dyes as tools for protein characterization
A Hawe, M Sutter, W Jiskoot
Pharmaceutical research 25 (7), 1487-1499, 2008
10062008
Protein instability in poly (lactic-co-glycolic acid) microparticles
M van de Weert, WE Hennink, W Jiskoot
Pharmaceutical research 17 (10), 1159-1167, 2000
7982000
Structure-immunogenicity relationships of therapeutic proteins
S Hermeling, DJA Crommelin, H Schellekens, W Jiskoot
Pharmaceutical research 21 (6), 897-903, 2004
6482004
Chitosan-based delivery systems for protein therapeutics and antigens
M Amidi, E Mastrobattista, W Jiskoot, WE Hennink
Advanced drug delivery reviews 62 (1), 59-82, 2010
6062010
Identification of formaldehyde-induced modifications in proteins: reactions with model peptides
B Metz, GFA Kersten, P Hoogerhout, HF Brugghe, HAM Timmermans, ...
Journal of Biological Chemistry 279 (8), 6235-6243, 2004
6032004
Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality
JF Carpenter, TW Randolph, WIM Jiskoot, DJA Crommelin, CR Middaugh, ...
Journal of pharmaceutical sciences 98 (4), 1201-1205, 2009
5012009
Microneedle technologies for (trans) dermal drug and vaccine delivery
K van der Maaden, W Jiskoot, J Bouwstra
Journal of controlled release 161 (2), 645-655, 2012
4442012
Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system
M Amidi, SG Romeijn, G Borchard, HE Junginger, WE Hennink, W Jiskoot
Journal of controlled release 111 (1-2), 107-116, 2006
4322006
ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity
MI De Jonge, G Pehau-Arnaudet, MM Fretz, F Romain, D Bottai, P Brodin, ...
Journal of bacteriology 189 (16), 6028-6034, 2007
3222007
Strategies for the assessment of protein aggregates in pharmaceutical biotech product development
J Den Engelsman, P Garidel, R Smulders, H Koll, B Smith, S Bassarab, ...
Pharmaceutical research 28 (4), 920-933, 2011
2652011
N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model
M Amidi, SG Romeijn, JC Verhoef, HE Junginger, L Bungener, ...
Vaccine 25 (1), 144-153, 2007
2652007
Shifting paradigms: biopharmaceuticals versus low molecular weight drugs
DJA Crommelin, G Storm, R Verrijk, L de Leede, W Jiskoot, WE Hennink
International journal of pharmaceutics 266 (1-2), 3-16, 2003
2462003
Antibody response to aggregated human interferon alpha2b in wild-type and transgenic immune tolerant mice depends on type and level of aggregation
S Hermeling, H Schellekens, C Maas, MFBG Gebbink, DJA Crommelin, ...
Journal of pharmaceutical sciences 95 (5), 1084-1096, 2006
2432006
Functional characterization of an endosome-disruptive peptide and its application in cytosolic delivery of immunoliposome-entrapped proteins
E Mastrobattista, GA Koning, L van Bloois, ACS Filipe, W Jiskoot, G Storm
Journal of Biological Chemistry 277 (30), 27135-27143, 2002
2292002
Protein instability and immunogenicity: roadblocks to clinical application of injectable protein delivery systems for sustained release
W Jiskoot, TW Randolph, DB Volkin, CR Middaugh, C Schöneich, ...
Journal of pharmaceutical sciences 101 (3), 946-954, 2012
2152012
Structural properties of monoclonal antibody aggregates induced by freeze–thawing and thermal stress
A Hawe, JC Kasper, W Friess, W Jiskoot
European journal of pharmaceutical sciences 38 (2), 79-87, 2009
2142009
Synthesis, characterization and in vitro biological properties of O-methyl free N, N, N-trimethylated chitosan
RJ Verheul, M Amidi, S van der Wal, E van Riet, W Jiskoot, WE Hennink
Biomaterials 29 (27), 3642-3649, 2008
2112008
Forced degradation of therapeutic proteins
A Hawe, M Wiggenhorn, M van de Weert, JHO Garbe, H Mahler, ...
Journal of pharmaceutical sciences 101 (3), 895-913, 2012
2032012
Advances in transcutaneous vaccine delivery: do all ways lead to Rome?
SM Bal, Z Ding, E van Riet, W Jiskoot, JA Bouwstra
Journal of controlled release 148 (3), 266-282, 2010
2022010
The system can't perform the operation now. Try again later.
Articles 1–20